vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and INTERFACE INC (TILE). Click either name above to swap in a different company.
INTERFACE INC is the larger business by last-quarter revenue ($349.4M vs $196.0M, roughly 1.8× Axsome Therapeutics, Inc.). INTERFACE INC runs the higher net margin — 7.0% vs -14.6%, a 21.6% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 4.3%). INTERFACE INC produced more free cash flow last quarter ($28.6M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 9.8%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Interface, Inc., headquartered in Atlanta, Georgia, is a global manufacturer of commercial flooring. The company sells modular carpet tiles, luxury vinyl tile, and Nora brand rubber flooring.
AXSM vs TILE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $349.4M |
| Net Profit | $-28.6M | $24.4M |
| Gross Margin | — | 38.6% |
| Operating Margin | -13.8% | 10.1% |
| Net Margin | -14.6% | 7.0% |
| Revenue YoY | 65.0% | 4.3% |
| Net Profit YoY | 61.9% | 12.1% |
| EPS (diluted) | $-0.55 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $349.4M | ||
| Q3 25 | $171.0M | $364.5M | ||
| Q2 25 | $150.0M | $375.5M | ||
| Q1 25 | $121.5M | $297.4M | ||
| Q4 24 | $118.8M | $335.0M | ||
| Q3 24 | $104.8M | $344.3M | ||
| Q2 24 | $87.2M | $346.6M | ||
| Q1 24 | $75.0M | $289.7M |
| Q4 25 | $-28.6M | $24.4M | ||
| Q3 25 | $-47.2M | $46.1M | ||
| Q2 25 | $-48.0M | $32.6M | ||
| Q1 25 | $-59.4M | $13.0M | ||
| Q4 24 | $-74.9M | $21.8M | ||
| Q3 24 | $-64.6M | $28.4M | ||
| Q2 24 | $-79.3M | $22.6M | ||
| Q1 24 | $-68.4M | $14.2M |
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.4% | ||
| Q1 25 | — | 37.3% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 38.1% |
| Q4 25 | -13.8% | 10.1% | ||
| Q3 25 | -27.0% | 14.6% | ||
| Q2 25 | -24.5% | 13.9% | ||
| Q1 25 | -46.9% | 7.8% | ||
| Q4 24 | -61.1% | 8.8% | ||
| Q3 24 | -59.8% | 12.3% | ||
| Q2 24 | -89.5% | 11.0% | ||
| Q1 24 | -89.7% | 8.4% |
| Q4 25 | -14.6% | 7.0% | ||
| Q3 25 | -27.6% | 12.7% | ||
| Q2 25 | -32.0% | 8.7% | ||
| Q1 25 | -48.9% | 4.4% | ||
| Q4 24 | -63.1% | 6.5% | ||
| Q3 24 | -61.7% | 8.3% | ||
| Q2 24 | -91.0% | 6.5% | ||
| Q1 24 | -91.1% | 4.9% |
| Q4 25 | $-0.55 | $0.41 | ||
| Q3 25 | $-0.94 | $0.78 | ||
| Q2 25 | $-0.97 | $0.55 | ||
| Q1 25 | $-1.22 | $0.22 | ||
| Q4 24 | $-1.54 | $0.38 | ||
| Q3 24 | $-1.34 | $0.48 | ||
| Q2 24 | $-1.67 | $0.38 | ||
| Q1 24 | $-1.44 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $71.3M |
| Total DebtLower is stronger | — | $181.6M |
| Stockholders' EquityBook value | $88.3M | $640.7M |
| Total Assets | $689.8M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $71.3M | ||
| Q3 25 | $325.3M | $187.4M | ||
| Q2 25 | $303.0M | $121.7M | ||
| Q1 25 | $300.9M | $97.8M | ||
| Q4 24 | $315.4M | $99.2M | ||
| Q3 24 | $327.3M | $115.6M | ||
| Q2 24 | $315.7M | $94.2M | ||
| Q1 24 | $331.4M | $89.8M |
| Q4 25 | — | $181.6M | ||
| Q3 25 | — | $307.8M | ||
| Q2 25 | — | $304.4M | ||
| Q1 25 | — | $302.9M | ||
| Q4 24 | — | $302.8M | ||
| Q3 24 | — | $337.9M | ||
| Q2 24 | — | $387.6M | ||
| Q1 24 | — | $391.8M |
| Q4 25 | $88.3M | $640.7M | ||
| Q3 25 | $73.7M | $621.0M | ||
| Q2 25 | $73.1M | $575.0M | ||
| Q1 25 | $53.2M | $513.1M | ||
| Q4 24 | $57.0M | $489.1M | ||
| Q3 24 | $92.9M | $501.6M | ||
| Q2 24 | $102.9M | $451.2M | ||
| Q1 24 | $144.0M | $428.5M |
| Q4 25 | $689.8M | $1.2B | ||
| Q3 25 | $669.3M | $1.3B | ||
| Q2 25 | $639.8M | $1.3B | ||
| Q1 25 | $596.7M | $1.2B | ||
| Q4 24 | $568.5M | $1.2B | ||
| Q3 24 | $561.5M | $1.2B | ||
| Q2 24 | $548.2M | $1.2B | ||
| Q1 24 | $545.7M | $1.2B |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | — | 0.91× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $49.3M |
| Free Cash FlowOCF − Capex | $-18.7M | $28.6M |
| FCF MarginFCF / Revenue | -9.6% | 8.2% |
| Capex IntensityCapex / Revenue | 0.0% | 5.9% |
| Cash ConversionOCF / Net Profit | — | 2.02× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $121.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $49.3M | ||
| Q3 25 | $1.0M | $76.7M | ||
| Q2 25 | $-32.4M | $30.1M | ||
| Q1 25 | $-43.4M | $11.7M | ||
| Q4 24 | $-26.2M | $38.0M | ||
| Q3 24 | $-18.6M | $76.2M | ||
| Q2 24 | $-30.1M | $21.5M | ||
| Q1 24 | $-53.5M | $12.6M |
| Q4 25 | $-18.7M | $28.6M | ||
| Q3 25 | $988.0K | $66.1M | ||
| Q2 25 | $-32.4M | $22.8M | ||
| Q1 25 | $-43.7M | $4.3M | ||
| Q4 24 | $-26.2M | $24.4M | ||
| Q3 24 | $-18.7M | $69.7M | ||
| Q2 24 | $-30.2M | $12.0M | ||
| Q1 24 | $-53.6M | $8.6M |
| Q4 25 | -9.6% | 8.2% | ||
| Q3 25 | 0.6% | 18.1% | ||
| Q2 25 | -21.6% | 6.1% | ||
| Q1 25 | -36.0% | 1.4% | ||
| Q4 24 | -22.1% | 7.3% | ||
| Q3 24 | -17.9% | 20.3% | ||
| Q2 24 | -34.6% | 3.5% | ||
| Q1 24 | -71.4% | 3.0% |
| Q4 25 | 0.0% | 5.9% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | 0.0% | 2.0% | ||
| Q1 25 | 0.3% | 2.5% | ||
| Q4 24 | 0.0% | 4.1% | ||
| Q3 24 | 0.1% | 1.9% | ||
| Q2 24 | 0.1% | 2.8% | ||
| Q1 24 | 0.1% | 1.4% |
| Q4 25 | — | 2.02× | ||
| Q3 25 | — | 1.66× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | — | 2.68× | ||
| Q2 24 | — | 0.95× | ||
| Q1 24 | — | 0.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
TILE
| AMS | $205.9M | 59% |
| EAAA | $143.5M | 41% |
